MedPath
TGA Approval

AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector (444941)

444941

AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector

Celltrion Healthcare Australia Pty Ltd

May 30, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

Tocilizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector (444941) - TGA 批准文号 | MedPath